Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00920881 · ClinicalTrials.gov registry record
Clinical Evaluation of the Accuracy of the FreeStyle Navigator Continuous Glucose Monitoring System
A clinical trial, sponsored by Abbott Diabetes Care.
- Completed
- Registry status
- 58
- Enrollment target
NCT00920881: Completed study, sponsored by Abbott Diabetes Care.
NCT00920881 is a clinical trial that has completed, run by Abbott Diabetes Care. The registered enrollment target is 58 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00920881 has completed, sponsored by Abbott Diabetes Care.
- COMPLETED
- Registry status
- 58 participants
- Enrollment target
Study Summary
To evaluate the clinical accuracy of the FreeStyle Navigator Continuous Glucose Monitoring System with respect to a reference standard.
Interventions
- DEVICE FreeStyle Navigator Continuous Glucose Monitoring System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2005-11 |
| Est. Completion | 2005-12 |
What the finished NCT00920881 record still lists
NCT00920881 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 58 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which FreeStyle Navigator Continuous Glucose Monitoring System is the first listed.
NCT00920881 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00920881 about?
NCT00920881 is a clinical study titled "Clinical Evaluation of the Accuracy of the FreeStyle Navigator Continuous Glucose Monitoring System". To evaluate the clinical accuracy of the FreeStyle Navigator Continuous Glucose Monitoring System with respect to a reference standard.
What is the current status of trial NCT00920881?
This trial is currently completed. The enrollment target is 58 participants. The study started on 2005-11. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00920881?
The interventions under investigation include: FreeStyle Navigator Continuous Glucose Monitoring System (DEVICE).
Who is sponsoring clinical trial NCT00920881?
This trial is sponsored by Abbott Diabetes Care, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia